FNT
ABBV icon

First National Trust’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$23.3M Sell
125,589
-2,254
-2% -$418K 0.87% 23
2025
Q1
$26.8M Sell
127,843
-13,852
-10% -$2.9M 1.08% 19
2024
Q4
$25.2M Buy
141,695
+11,045
+8% +$1.96M 0.95% 22
2024
Q3
$25.8M Sell
130,650
-2,186
-2% -$432K 1% 20
2024
Q2
$22.8M Sell
132,836
-4,538
-3% -$778K 0.94% 22
2024
Q1
$25M Sell
137,374
-3,705
-3% -$675K 1.02% 19
2023
Q4
$21.9M Sell
141,079
-8,970
-6% -$1.39M 0.96% 22
2023
Q3
$22.4M Sell
150,049
-3,092
-2% -$461K 1.07% 21
2023
Q2
$20.6M Sell
153,141
-671
-0.4% -$90.4K 0.96% 23
2023
Q1
$24.5M Buy
153,812
+587
+0.4% +$93.6K 1.3% 15
2022
Q4
$24.8M Buy
153,225
+5,943
+4% +$960K 1.31% 15
2022
Q3
$19.8M Buy
147,282
+26,055
+21% +$3.5M 1.15% 19
2022
Q2
$18.6M Sell
121,227
-2,580
-2% -$395K 1.04% 20
2022
Q1
$20.1M Buy
123,807
+1,343
+1% +$218K 1.04% 17
2021
Q4
$16.6M Buy
122,464
+829
+0.7% +$112K 0.87% 26
2021
Q3
$13.1M Sell
121,635
-338
-0.3% -$36.5K 0.78% 32
2021
Q2
$13.7M Sell
121,973
-4,407
-3% -$496K 0.84% 30
2021
Q1
$13.7M Sell
126,380
-8,999
-7% -$974K 0.9% 27
2020
Q4
$14.5M Sell
135,379
-692
-0.5% -$74.1K 1% 20
2020
Q3
$11.9M Sell
136,071
-6,287
-4% -$551K 0.93% 30
2020
Q2
$14M Sell
142,358
-1,770
-1% -$174K 1.18% 13
2020
Q1
$11M Sell
144,128
-1,930
-1% -$147K 1.1% 19
2019
Q4
$12.9M Buy
146,058
+971
+0.7% +$86K 1.05% 21
2019
Q3
$11M Buy
145,087
+7,436
+5% +$563K 0.99% 25
2019
Q2
$10M Buy
137,651
+440
+0.3% +$32K 0.93% 29
2019
Q1
$11.1M Buy
137,211
+223
+0.2% +$18K 1.11% 19
2018
Q4
$12.6M Buy
136,988
+2,008
+1% +$185K 1.41% 16
2018
Q3
$12.8M Sell
134,980
-4,568
-3% -$432K 1.3% 16
2018
Q2
$12.9M Buy
139,548
+2,885
+2% +$267K 1.42% 12
2018
Q1
$12.9M Buy
136,663
+5,658
+4% +$536K 1.47% 11
2017
Q4
$12.7M Sell
131,005
-1,050
-0.8% -$102K 1.39% 15
2017
Q3
$11.7M Buy
132,055
+1,195
+0.9% +$106K 1.36% 15
2017
Q2
$9.49M Buy
130,860
+4,663
+4% +$338K 1.16% 21
2017
Q1
$8.22M Buy
126,197
+1,805
+1% +$118K 1.07% 24
2016
Q4
$7.79M Sell
124,392
-1,661
-1% -$104K 1.1% 25
2016
Q3
$7.95M Buy
126,053
+708
+0.6% +$44.7K 1.2% 24
2016
Q2
$7.76M Buy
125,345
+1,030
+0.8% +$63.8K 1.19% 24
2016
Q1
$7.1M Buy
124,315
+1,655
+1% +$94.5K 1.09% 22
2015
Q4
$7.27M Buy
122,660
+63
+0.1% +$3.73K 1.15% 23
2015
Q3
$6.67M Buy
122,597
+4,170
+4% +$227K 1.14% 22
2015
Q2
$7.96M Buy
118,427
+5,689
+5% +$382K 1.28% 16
2015
Q1
$6.6M Buy
112,738
+12,497
+12% +$731K 1.13% 22
2014
Q4
$6.56M Buy
100,241
+3,289
+3% +$215K 1.17% 20
2014
Q3
$5.6M Buy
96,952
+3,188
+3% +$184K 1.06% 24
2014
Q2
$5.29M Buy
93,764
+5,775
+7% +$326K 1.02% 26
2014
Q1
$4.52M Buy
87,989
+3,557
+4% +$183K 0.81% 37
2013
Q4
$4.46M Buy
84,432
+2,725
+3% +$144K 0.81% 35
2013
Q3
$3.66M Buy
81,707
+5,296
+7% +$237K 0.72% 42
2013
Q2
$3.16M Buy
+76,411
New +$3.16M 0.65% 45